Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px
Document › Details

CureVac AG. (2/19/19). "Press Release: CureVac to Present at the 8th Annual Leerink Partners Global Healthcare Conference". Tübingen & Boston, MA.

Organisations Organisation CureVac AG
  Group CureVac (Group)
  Organisation 2 SVB Leerink LLC
Products Product SVB Leerink Annual Global Healthcare Conference 2019 New York
  Product 2 mRNA-based drug
Index term Index term CureVac–Silicon Valley Bank: investor conference, 201902 supply service CureVac presents at SVB Leerink Global Healthcare Conference in NYC
Person Person Menichella, Daniel (Dan) (CureVac 201705– CEO of CureVac Inc before Bamboo Therapeutics + Applied Genetic Technologies)
     


CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichella, Chief Executive Officer, will present a corporate overview at the 8th Annual Leerink Partners Global Healthcare Conference in New York on Wednesday, February 27, 2019 at 1:50 p.m. ET.

A live broadcast of the presentation will be available at www.curevac.com/en/newsroom/curevacevents. An archived replay of the presentation will be available on the company’s website for approximately 3 months following the presentation.


   
Record changed: 2019-03-04

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for CureVac (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top